MX363064B - Uso de mezclas polimericas para la produccion de formulaciones farmaceuticas recubiertas y formulacion farmaceutica con recubrimiento polimerico mezclado. - Google Patents
Uso de mezclas polimericas para la produccion de formulaciones farmaceuticas recubiertas y formulacion farmaceutica con recubrimiento polimerico mezclado.Info
- Publication number
- MX363064B MX363064B MX2007014024A MX2007014024A MX363064B MX 363064 B MX363064 B MX 363064B MX 2007014024 A MX2007014024 A MX 2007014024A MX 2007014024 A MX2007014024 A MX 2007014024A MX 363064 B MX363064 B MX 363064B
- Authority
- MX
- Mexico
- Prior art keywords
- polymer
- pharmaceutical formulation
- production
- polymers
- polymeric coating
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 10
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 239000011248 coating agent Substances 0.000 title abstract 3
- 238000000576 coating method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000000178 monomer Substances 0.000 abstract 4
- 239000013543 active substance Substances 0.000 abstract 2
- 150000004676 glycans Chemical class 0.000 abstract 2
- 229920001282 polysaccharide Polymers 0.000 abstract 2
- 239000005017 polysaccharide Substances 0.000 abstract 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 1
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 239000011521 glass Substances 0.000 abstract 1
- 125000003010 ionic group Chemical group 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
- 125000002348 vinylic group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se refiere al uso de una mezcla de 2 a 60% en peso de uno o varios polímeros (I) con 40 a 98% en peso de uno o varios polímeros (II), siendo que el polímero (I) es un copolímero de (met)acrilato que contiene 90 a 100% en peso de unidades polimerizadas por radicales libres de 40 a 95% en peso de C1 a C4 alquilésteres del ácido acrílico o metacrílico, y 5 a 60% en peso de unidades de monómeros de (met)acrilato con un grupo aniónico, y 0 a 10% en peso de otros monómeros polimerizables vinílicamente, y el polímero (II), es un vinilpolímero distinto al polímero (I) o un polisacárido o un derivado de un polisacárido, que contiene 88 a 100% de unidades monoméricas neutrales y hasta 12% en peso de unidades monoméricas polimerizadas con radicales iónicos, para la producción de una formulación farmacéutica revestida que contiene un núcleo que presenta el ingrediente activo y un revestimiento polimérico de una mezcla de los polímeros (I) y (II), caracterizado porque la temperatura de transición vítrea del polímero (I) no es mayor a 70 °C y se obtiene un perfil de liberación de ingrediente activo en el que, en comparación con una formulación farmacéutica revestida únicamente con el polímero (I), el ingrediente activo se libera empezando en el mismo valor de pH pero más lentamente. La invención también se refiere a una formulación farmacéutica con un polímero (I) selecto.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005024614A DE102005024614A1 (de) | 2005-05-25 | 2005-05-25 | Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug |
PCT/EP2006/001949 WO2006125483A1 (de) | 2005-05-25 | 2006-03-03 | Verwendung vom polymermischungen zur herstellung von überzogenen arzneiformen sowie arzneiform mit |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2007014024A MX2007014024A (es) | 2008-04-09 |
MX363064B true MX363064B (es) | 2019-03-06 |
Family
ID=36607494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007014024A MX363064B (es) | 2005-05-25 | 2006-03-03 | Uso de mezclas polimericas para la produccion de formulaciones farmaceuticas recubiertas y formulacion farmaceutica con recubrimiento polimerico mezclado. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20080193522A1 (es) |
EP (1) | EP1890682B1 (es) |
JP (1) | JP5582701B2 (es) |
KR (1) | KR101387835B1 (es) |
CN (1) | CN101137354B (es) |
BR (1) | BRPI0610206B8 (es) |
CA (1) | CA2606587C (es) |
DE (1) | DE102005024614A1 (es) |
ES (1) | ES2628962T3 (es) |
HK (1) | HK1116341A1 (es) |
HU (1) | HUE032869T2 (es) |
IL (1) | IL187535A0 (es) |
MX (1) | MX363064B (es) |
PL (1) | PL1890682T3 (es) |
SI (1) | SI1890682T1 (es) |
WO (1) | WO2006125483A1 (es) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5563735B2 (ja) | 2004-06-16 | 2014-07-30 | タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド | Ppi多回剤形 |
US20080292695A1 (en) * | 2006-12-01 | 2008-11-27 | Kristin Arnold | Carvedilol forms, compositions, and methods of preparation thereof |
EP2124552A4 (en) * | 2007-01-31 | 2013-01-09 | Methylation Sciences Internat Srl | PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE OF S-ADENOSYLMETHIONINE |
CA2699227C (en) * | 2007-09-21 | 2014-12-02 | Evonik Roehm Gmbh | Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
CN101801356B (zh) * | 2007-09-21 | 2016-10-19 | 赢创罗姆有限公司 | 耐受乙醇影响的非阿片类的pH依赖性受控释放的药物组合物 |
KR20150084013A (ko) * | 2007-10-12 | 2015-07-21 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 음식 섭취와 관계없이 위장 장애를 치료하는 방법 |
US9241910B2 (en) | 2008-03-11 | 2016-01-26 | Takeda Pharmaceutical Company Limited | Orally-disintegrating solid preparation |
RU2011102777A (ru) * | 2008-06-26 | 2012-08-10 | МакНЕЙЛ-ППС, ИНК. (US) | Частицы с покрытием, содержащие фармацевтически активные агенты |
PL2326313T3 (pl) | 2008-09-24 | 2015-08-31 | Evonik Roehm Gmbh | Kompozycja farmaceutyczna o zależnym od pH kontrolowanym uwalnianiu dla nieopioidów z odpornością przed wpływem etanolu |
CN104984343B (zh) * | 2008-09-24 | 2019-04-02 | 赢创罗姆有限公司 | 耐受乙醇影响的非阿片类药物的pH依赖性受控释放的药物组合物 |
US9757343B2 (en) * | 2008-09-24 | 2017-09-12 | Evonik Röhm Gmbh | PH-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
US20100143461A1 (en) * | 2008-12-08 | 2010-06-10 | Ben-Zion Solomon | Palonosetron formulation |
CN105287434A (zh) * | 2009-03-18 | 2016-02-03 | 赢创罗姆有限公司 | 采用含有中性乙烯基聚合物和赋形剂的包衣的具有耐乙醇影响的控释药物组合物 |
BRPI0924427A2 (pt) * | 2009-03-18 | 2016-01-26 | Evonik Roehm Gmbh | composição farmacêutica de liberação controlada, seu processo de preparação e uso da mesma |
MX2011009667A (es) | 2009-03-18 | 2011-12-14 | Evonik Roehm Gmbh | Composición farmacéutica de liberación controlada con resistencia a la influencia de etanol mediante el uso de un revestimiento compuesto de polímeros de vinilo neutrales y excipientes. |
US20100303920A1 (en) * | 2009-05-27 | 2010-12-02 | Johan Hjartstam | Aqueous Film Coating Composition / 841 |
US8329208B2 (en) | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
ES2720869T3 (es) * | 2009-10-22 | 2019-07-25 | Synthon Bv | Composiciones farmacéuticas de sevelámero |
RU2649806C2 (ru) * | 2011-06-17 | 2018-04-04 | Эвоник Рем ГмбХ | Желудочно-резистентная фармацевтическая или нутрицевтическая композиция с устойчивостью к воздействию этанола |
CA3018328A1 (en) | 2014-10-31 | 2016-04-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
JP6824197B2 (ja) | 2015-06-05 | 2021-02-03 | エボニック オペレーションズ ゲーエムベーハー | エタノールの影響に対する耐性を有する医薬品組成物または栄養機能食品組成物 |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
JP6739275B2 (ja) * | 2016-08-02 | 2020-08-12 | 日本化薬株式会社 | ゲフィチニブを有効成分とする医薬組成物 |
IT201700032367A1 (it) * | 2017-03-23 | 2018-09-23 | Lamberti Spa | Dispersioni poliuretaniche acquose |
WO2019170485A1 (en) | 2018-03-09 | 2019-09-12 | Evonik Röhm Gmbh | Polymer mixture with resistance against the influence of ethanol |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
KR20220002604A (ko) * | 2019-06-07 | 2022-01-06 | 닛뽕소다 가부시키가이샤 | 미립자용 습식 코팅제 |
WO2020249505A1 (en) * | 2019-06-13 | 2020-12-17 | Evonik Operations Gmbh | Powder composition comprising a copolymer mixture and a water-soluble cellulose |
CN111700871A (zh) * | 2020-06-24 | 2020-09-25 | 杭州巴洛特生物科技有限公司 | 一种美沙拉嗪组合物及其制备方法 |
CN112237572A (zh) * | 2020-10-28 | 2021-01-19 | 海南卫康制药(潜山)有限公司 | 一种富马酸沃诺拉赞片剂及其制备方法 |
CN114409998A (zh) * | 2021-12-24 | 2022-04-29 | 浙江普利特新材料有限公司 | 一种蜂窝状咖啡炭复合隔音降噪聚丙烯材料及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5019397A (en) * | 1988-04-21 | 1991-05-28 | Alza Corporation | Aqueous emulsion for pharmaceutical dosage form |
IT1227899B (it) * | 1988-12-23 | 1991-05-14 | Poli Ind Chimica Spa | Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni |
DE9414066U1 (de) * | 1994-08-31 | 1994-11-03 | Roehm Gmbh | Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform |
JPH09323926A (ja) * | 1996-03-15 | 1997-12-16 | Nikken Chem Co Ltd | バルプロ酸ナトリウムの徐放性錠剤 |
IL148411A0 (en) * | 1999-08-31 | 2002-09-12 | Gruenenthal Chemie | Delayed-action form of administration containing tramadol saccharinate |
DE10013029A1 (de) * | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
IL159584A0 (en) * | 2001-07-16 | 2004-06-01 | Astrazeneca Ab | Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
HUP0401732A2 (hu) * | 2001-10-15 | 2004-12-28 | Röhm GmbH & Co. KG | Kopolimerek használata aktív szerként peptidet és fehérjét tartalmazó galenikus formák előállításához |
US20040091538A1 (en) * | 2002-10-31 | 2004-05-13 | Crystal Pollock-Dove | Dosage form providing ascending release of liquid formulation |
WO2004062577A2 (en) * | 2003-01-03 | 2004-07-29 | Shire Laboratories Inc. | Two or more enteric materials to regulate drug release |
MXPA04010956A (es) * | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Forma de dosis farmaceutica y metodo para la produccion de la misma. |
ATE549015T1 (de) * | 2003-10-31 | 2012-03-15 | Hexal Ag | Pharmazeutische wirkstoffhaltige formulierung mit überzug |
-
2005
- 2005-05-25 DE DE102005024614A patent/DE102005024614A1/de not_active Withdrawn
-
2006
- 2006-03-03 CA CA2606587A patent/CA2606587C/en active Active
- 2006-03-03 WO PCT/EP2006/001949 patent/WO2006125483A1/de not_active Application Discontinuation
- 2006-03-03 CN CN200680007508.8A patent/CN101137354B/zh not_active Expired - Fee Related
- 2006-03-03 JP JP2008512703A patent/JP5582701B2/ja not_active Expired - Fee Related
- 2006-03-03 BR BRPI0610206A patent/BRPI0610206B8/pt not_active IP Right Cessation
- 2006-03-03 KR KR1020077027199A patent/KR101387835B1/ko active IP Right Grant
- 2006-03-03 US US11/909,315 patent/US20080193522A1/en not_active Abandoned
- 2006-03-03 MX MX2007014024A patent/MX363064B/es unknown
- 2006-03-03 SI SI200632186T patent/SI1890682T1/sl unknown
- 2006-03-03 EP EP06723193.6A patent/EP1890682B1/de active Active
- 2006-03-03 HU HUE06723193A patent/HUE032869T2/en unknown
- 2006-03-03 PL PL06723193T patent/PL1890682T3/pl unknown
- 2006-03-03 ES ES06723193.6T patent/ES2628962T3/es active Active
-
2007
- 2007-11-21 IL IL187535A patent/IL187535A0/en unknown
-
2008
- 2008-06-18 HK HK08106684.0A patent/HK1116341A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE102005024614A1 (de) | 2006-11-30 |
EP1890682A1 (de) | 2008-02-27 |
CN101137354A (zh) | 2008-03-05 |
BRPI0610206B1 (pt) | 2020-10-06 |
CA2606587C (en) | 2015-05-26 |
HK1116341A1 (en) | 2008-12-19 |
US20080193522A1 (en) | 2008-08-14 |
HUE032869T2 (en) | 2017-11-28 |
IL187535A0 (en) | 2008-03-20 |
PL1890682T3 (pl) | 2017-10-31 |
MX2007014024A (es) | 2008-04-09 |
BRPI0610206A2 (pt) | 2010-06-01 |
ES2628962T3 (es) | 2017-08-04 |
SI1890682T1 (sl) | 2017-10-30 |
JP5582701B2 (ja) | 2014-09-03 |
EP1890682B1 (de) | 2017-05-03 |
JP2008542211A (ja) | 2008-11-27 |
CA2606587A1 (en) | 2006-11-30 |
WO2006125483A1 (de) | 2006-11-30 |
KR20080009213A (ko) | 2008-01-25 |
BRPI0610206B8 (pt) | 2022-07-05 |
KR101387835B1 (ko) | 2014-04-25 |
CN101137354B (zh) | 2014-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX363064B (es) | Uso de mezclas polimericas para la produccion de formulaciones farmaceuticas recubiertas y formulacion farmaceutica con recubrimiento polimerico mezclado. | |
WO2007006353A3 (de) | Verwendung eines teilneutralisierten, anionischen (meth) acrylat-copolymers als uberzug fur die herstellung einer arzneiform mit einer wirkstofffreisetzung bei erniedrigten ph-werten | |
AU2003266351A1 (en) | Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers | |
ATE438693T1 (de) | Wässriges überzugsmittel, verfahren zu seiner herstellung und seine verwendung | |
CN101787231A (zh) | 憎水改性缔合型增稠剂及其制备方法 | |
ATE383391T1 (de) | Formmasse, enthaltend ein mattierungsmittel | |
WO2002022754A8 (en) | Adhesive compositions containing low molecular weight polymeric additives | |
TW200500046A (en) | Color-stable superabsorbent polymer composition | |
WO2006010394A3 (de) | Mehrschichtige arzneiform | |
DE502004001110D1 (de) | Redispersionspulver-zusammensetzung mit abbindebesschleunigender wirkung | |
KR20160056878A (ko) | 저예사성 증점제 및 이 증점제를 배합한 화장료 | |
WO2006117362A8 (de) | Verwendung silicium enthaltender polymerisate als bauklebstoffe | |
IL185218A0 (en) | Partly neutralised anionic (meth) acrylate copolymer | |
ATE406954T1 (de) | Polymerische dispergiermittel als verflüssigungsmittel in zusammensetzungen von hydraulischen bindemitteln und verfahren zu deren herstellung | |
WO2005059048A8 (en) | Coating compositions containing levelling agents prepared by nitroxyl mediated polymerisation | |
MX2008016485A (es) | Procedimiento de polimerización por radicales libres en dispersión acuosa para la preparación de polímeros. | |
KR20190124318A (ko) | 경화성 조성물, 시트, 그것을 이용한 적층체, 화상 표시 장치 | |
ATE432966T1 (de) | Verwendung von mit schutzkolloid stabilisierten mischpolymerisaten in zementfreien beschichtungsmitteln | |
ATE273333T1 (de) | (co-)polymerisate von hydroxyalkyl(meth)acrylaten,verfahren zu deren herstellung sowie deren verwendung in pharmazeutischen darreichungsformen | |
JP2013543026A (ja) | 溶液中でフリーラジカル重合によって第三アミノ基を含む(メタ)アクリレートコポリマーを製造する方法 | |
JP2008525547A5 (es) | ||
ATE350403T1 (de) | Modifizierte polyvinylalkohole enthaltende polymerzusammensetzungen | |
JPS62270608A (ja) | 水溶性アクリル系共重合体の製造方法 | |
AU2002232434A1 (en) | Water-based coating composition having carbonate-amine cross-linking, method of preparing the same, and a cured film thereof | |
ATE173286T1 (de) | Wässrige überzugsmittel |